NLRP3 and myocardial infarction: In MI/R injury, HSYA suppressed the NLRP3 inflammasome by modulating the AMPK/mTOR signaling pathway, thereby reducing myocardial infarct size and decreasing cardiomyocyte apoptosis, ultimately improving heart function (143).